Skip to content

Development of a Polyphenol-rich Dietary Preparation for Treating Veterans With Gulf War Illness

Development of a Polyphenol-rich Dietary Preparation for Treating Veterans With Gulf War Illness

Status
Completed
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02915237
Enrollment
36
Registered
2016-09-26
Start date
2016-08-31
Completion date
2019-01-17
Last updated
2020-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gulf War Illness

Keywords

Veterans, Gulf War Illness, Gulf War Veterans's Illness, Gulf War Veterans' Medically Unexplained Illnesses

Brief summary

Gulf War Illness (GWI) is a multi-symptom disorder that is characterized by complex traits such as fatigue, headaches, joint pain, insomnia, and memory problems. With no treatment for GWI currently available, there is an urgent need to develop novel interventions to alleviate major GWI clinical complications. Recent evidence highlights the potential value of flavonoids, a subclass of organic chemical called polyphenols abundantly found in some plants and common dietary preparations, in helping relieve clinical complications in Veterans with GWI. The overall goal is to test whether daily consumption of commercially available Concord grape juice, which is very Flavonoid-rich, is effective for treating cognitive deficits and chronic fatigue in Veterans with GWI.

Detailed description

Gulf War Illness (GWI) is a multi-symptom disorder that is characterized by complex traits. Clinical complications of GWI typically persist over long-term, cause significant pain and suffering, and interfere with the ability of affected Veterans to successfully integrate back into civilian society. There is no treatment for GWI and there is an urgent need to develop novel interventions either to resolve underlying GWI mechanisms, or to alleviate major GWI clinical complications. Recent Evidence highlights the potential value of flavonoids, a subclass of organic chemical called polyphenols that are abundantly found in some plants and common dietary preparations may help alleviate chronic fatigue and preserve cognitive functions. Based on this, the overall goal is to test whether the potential efficacy of dietary supplementation with a commercially available flavonoid-rich product, alleviates clinical complications in Veterans with GWI. In particular, the researchers propose a randomized, double-blind, placebo-controlled Phase I/IIA study to test the feasibility and potential efficacy of Concord grape juice dietary supplementation to treat cognitive deficits and chronic fatigue in Veterans with GWI.

Interventions

DIETARY_SUPPLEMENTConcord grape juice

Daily dietary supplementation with a commercially available Concord grape juice.

DIETARY_SUPPLEMENTPlacebo Beverage

Daily dietary supplementation with a placebo beverage consisting of water, sugar, artificial flavoring and color that is formulated to look and taste like grape juice and have the same carbohydrate composition and energy load.

Sponsors

United States Department of Defense
CollaboratorFED
Department of Veterans Affairs, New Jersey
CollaboratorFED
Icahn School of Medicine at Mount Sinai
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Gulf War Veterans deployed to the Persian Gulf theatre between August 1990 and August 1991. GWI will be defined according to the Kansas Case Definition. The Kansas Case Definition identifies 6 symptom domains and requires endorsement of moderately severe and/or multiple symptoms in at least 3 of those domains. To meet the case definition, the Veterans must also indicate that each symptom first became problematic during or within one year of the Gulf War.

Exclusion criteria

* Individuals not meeting the inclusion criteria for Gulf War deployment and definition of GWI, or with conditions that might interfere with their ability to report their symptoms (e.g., drug use) are excluded. * Additional

Design outcomes

Primary

MeasureTime frameDescription
Brief Symptom Inventory (BSI)6 monthsto assess safety and tolerability to treatment. The test is a 53-item self report scale that uses the 5 point Likert scale.
Patient Health Questionnaire-15 (PHQ-15)6 monthsto assess safety and tolerability to treatment. The Patient Health Questionnaire 15 (PHQ 15) is a validated measure of somatic symptom severity in functional somatic syndromes (FSS). Scale ranges from 0-30 (mild to severe).
California Verbal Learning Test-Second Edition (CVLT-II)6 monthsThis test looks at cognitive functioning by assessing immediate recall and long-delayed recall.
The Chalder Fatigue Questionnaire6 monthsThe Chalder Fatigue Questionnaire assess chronic fatigue. Each of the 11 items are answered on a 4-point scale ranging from the asymptomatic to maximum symptomology

Secondary

MeasureTime frameDescription
the Stroop Test6 monthsThe Stroop Color and Word Test consists of a Word Page with color words printed in black ink, a Color Page with 'Xs' printed in color, and a color-Word Page with words from the first page printed in colors from the second page (the color and the word do not match). The respondent goes down each sheet reading words or naming the ink colors as quickly as possible within a time limit. The test yields three scores based on the number of items completed on each of the three stimulus sheets. An Interference score, which is useful in determining the individual's cognitive flexibility, creativity, and reaction to cognitive pressures also can be calculated.
Halstead Category Test6 monthsThis test takes approximately 30 minutes and consists of 120 items, presented visually. The participant must decipher the underlying principle of the stimulus set. Total number of errors will be used.
Wechsler Adult Intelligence Scale (WAIS-IV)6 monthsThe Digit Span subtest is a widely used measure of auditory attention that is well-normed and sensitive. The subtest has three parts - digits forward, backward, and sequencing.
Wechsler Adult Intelligence Scale-Fourth Edition (WAIS-IV) Digit Span Subtest6 monthsDigit Span measures short-term auditory memory and attention.
Brief Visuospatial Memory Test-Revised (BVMT-R)6 monthsA tool to measure visuospatial learning and memory abilities.
the Conner's Continuous Performance Test-3 (CPT-3)6 monthsThe CPT-3 assist in clinical assessment of attention problems. The patient is instructed to press the space bar (or mouse button) immediately following the presentation of specific letters on screen. The test normally takes 14 minutes to administer.
the Trail Making Test (TMT)6 monthsThe TMT consists of two forms, parts A and B. This measure taps both simple graphomotor speed (Part A) and adds in a rapid set-shifting paradigm that taps executive functioning (Part B).
Wechsler Adult Intelligence Scale-Fourth Edition (WAIS-IV) Block Design Subtest6 monthsA tool for testing adult intelligence level.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026